4.5 Article

The Procalcitonin And Survival Study (PASS) -: A Randomised multi-center investigator-initiated trial to investigate whether daily measurements biomarker Procalcitonin and pro-active diagnostic and therapeutic responses to abnormal Procalcitonin levels, can improve survival in intensive care unit patients.: Calculated sample size (target population):: 1000 patients

Related references

Note: Only part of the references are listed.
Article Critical Care Medicine

Procalcitonin increase in early identification of critically ill patients at high risk of mortality

Jens Ulrik Jensen et al.

CRITICAL CARE MEDICINE (2006)

Article Medicine, General & Internal

A utilization management intervention to reduce unnecessary testing in the coronary care unit

TJ Wang et al.

ARCHIVES OF INTERNAL MEDICINE (2002)

Article Critical Care Medicine

Epidemiology of sepsis and infection in ICU patients from an international multicentre cohort study

C Alberti et al.

INTENSIVE CARE MEDICINE (2002)